HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX Drug Patent Profile
✉ Email this page to a colleague
Which patents cover Hydrocodone Polistirex And Chlorpheniramne Polistirex, and when can generic versions of Hydrocodone Polistirex And Chlorpheniramne Polistirex launch?
Hydrocodone Polistirex And Chlorpheniramne Polistirex is a drug marketed by Neos Theraps Inc and is included in one NDA.
The generic ingredient in HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX is chlorpheniramine polistirex; hydrocodone polistirex. There are twenty-nine drug master file entries for this compound. Three suppliers are listed for this compound. Additional details are available on the chlorpheniramine polistirex; hydrocodone polistirex profile page.
AI Research Assistant
Questions you can ask:
- What is the 5 year forecast for HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX?
- What are the global sales for HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX?
- What is Average Wholesale Price for HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX?
Summary for HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| DailyMed Link: | HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX at DailyMed |
US Patents and Regulatory Information for HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Neos Theraps Inc | HYDROCODONE POLISTIREX AND CHLORPHENIRAMNE POLISTIREX | chlorpheniramine polistirex; hydrocodone polistirex | SUSPENSION, EXTENDED RELEASE;ORAL | 091671-001 | Jun 29, 2012 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | ⤷ Subscribe | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
